Xylem (XYL) Revenue (2010 - 2026)

Xylem's Revenue history runs 17 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• On a quarterly basis, Revenue rose 2.71% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $9.1 billion, a 5.73% increase from a year earlier, with the FY2025 full-year figure at $9.0 billion, up 5.52% from the prior year.
• Revenue declined to $2.1 billion in Q1 2026 per XYL's latest filing, from $2.4 billion in the prior quarter.
• Across five years, Revenue topped out at $2.4 billion in Q4 2025 and bottomed at $1.3 billion in Q1 2022.
• The 5-year median for Revenue is $2.1 billion (2023), against an average of $1.9 billion.
• Across the five-year window, Revenue rose 0.96% in 2022 and surged 50.43% in 2023, its largest moves.
• Year by year, Revenue stood at $1.5 billion in 2022, then jumped by 40.64% to $2.1 billion in 2023, then advanced by 6.52% to $2.3 billion in 2024, then climbed by 6.25% to $2.4 billion in 2025, then retreated by 11.35% to $2.1 billion in 2026.
• Per Business Quant, the three latest XYL Revenue figures stand at $2.1 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.3 billion (Q3 2025).